| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 1.095.100.823 $ | +11.928.549 $ | +31,7 % | 47 | 1.202.954.264 $ | -464.012 $ | +10,6 % | 46 | 1.547.066.991 $ | +544.822.520 $ | +63,6 % | 47 | |||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 70.350.517 $ | -145.665.374 $ | -67,4 % | 1 | 216.015.891 $ | +164.228.839 $ | +317,1 % | 1 | |||||
| Cidara Therapeutics, Inc. | → 0 | 211.318.836 $ | +85.736.778 $ | +68,3 % | 1 | ||||||||||
| Erasca, Inc. | ERAS | → 0 | Neutral | 75.614.188 $ | -120.996.758 $ | -61,5 % | 1 | 196.610.946 $ | +162.113.794 $ | +469,9 % | 1 | 34.497.152 $ | +14.281.079 $ | +70,6 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Sehr schwach | 90.766.926 $ | -18.421.654 $ | -16,9 % | 1 | 109.188.580 $ | +12.250.068 $ | +12,6 % | 1 | 96.938.512 $ | +86.397.077 $ | +819,6 % | 1 |
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 95.015.558 $ | +34.236.169 $ | +56,3 % | 1 | 60.779.389 $ | -3.005.854 $ | -4,7 % | 1 | 63.785.243 $ | +17.169.031 $ | +36,8 % | 1 |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 16.254.327 $ | -68.957.904 $ | -80,9 % | 1 | 85.212.231 $ | +45.160.224 $ | +112,8 % | 1 | ||||
| ArriVent BioPharma, Inc. | AVBP | → 0 | Neutral | 58.436.050 $ | +37.997.968 $ | +185,9 % | 1 | 20.438.082 $ | +20.438.082 $ | 1 | |||||
| AVADEL PHARMACEUTICALS PLC | AVDL | → 0 | 57.842.549 $ | +16.856.205 $ | +41,1 % | 1 | |||||||||
| DBV Technologies S.A. | DBVT | → 0 | Schwach | 30.254.031 $ | -25.471.485 $ | -45,7 % | 1 | 55.725.516 $ | +8.536.146 $ | +18,1 % | 1 | 47.189.370 $ | +36.644.310 $ | +347,5 % | 1 |
| Abivax S.A. | ABVX | → 0 | Neutral | 55.289.441 $ | +28.616.773 $ | +107,3 % | 1 | 26.672.668 $ | -21.781.408 $ | -45,0 % | 1 | 48.454.076 $ | +17.949.081 $ | +58,8 % | 1 |
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 16.987.961 $ | -33.507.554 $ | -66,4 % | 1 | 50.495.515 $ | -763.637 $ | -1,5 % | 1 | 51.259.152 $ | +17.850.021 $ | +53,4 % | 1 |
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 34.591.320 $ | +6.354.461 $ | +22,5 % | 1 | 28.236.859 $ | -22.911.759 $ | -44,8 % | 1 | 51.148.618 $ | +18.069.374 $ | +54,6 % | 1 |
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 43.131.579 $ | -1.946.419 $ | -4,3 % | 1 | 45.077.998 $ | +25.986.647 $ | +136,1 % | 1 | 19.091.351 $ | +12.567.079 $ | +192,6 % | 1 |
| SAB Biotherapeutics, Inc. | SABS | → 0 | Neutral | 28.469.645 $ | -15.268.955 $ | -34,9 % | 1 | 43.738.600 $ | +1.027.800 $ | +2,4 % | 1 | 42.710.800 $ | +19.756.600 $ | +86,1 % | 1 |
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 41.918.891 $ | +869.803 $ | +2,1 % | 1 | 41.049.088 $ | +23.842.930 $ | +138,6 % | 1 | 17.206.158 $ | +737.407 $ | +4,5 % | 1 |
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 9.873.553 $ | -31.560.734 $ | -76,2 % | 1 | 41.434.287 $ | -112.572.236 $ | -73,1 % | 1 | |||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Neutral | 39.113.474 $ | -1.543.367 $ | -3,8 % | 1 | 40.656.841 $ | +1.510.650 $ | +3,9 % | 1 | 39.146.191 $ | +8.718.104 $ | +28,7 % | 1 |
| SINOVAC BIOTECH LTD | SVA | → 0 | 38.192.410 $ | +0 $ | +0,0 % | 1 | 38.192.410 $ | +0 $ | +0,0 % | 1 | 38.192.410 $ | +0 $ | +0,0 % | 1 | |
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Schwach | 36.375.000 $ | +33.043.755 $ | +991,9 % | 1 | 3.331.245 $ | +791.666 $ | +31,2 % | 1 | 2.539.579 $ | +954.165 $ | +60,2 % | 1 |
| GERON CORP | GERN | → 0 | Neutral | 11.099.900 $ | -1.821.078 $ | -14,1 % | 1 | 12.920.978 $ | -23.016.407 $ | -64,0 % | 1 | 35.937.385 $ | -1.361.265 $ | -3,6 % | 1 |
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Schwach | 35.414.630 $ | +10.414.632 $ | +41,7 % | 1 | 24.999.998 $ | -1.755.555 $ | -6,6 % | 1 | 26.755.553 $ | +9.866.666 $ | +58,4 % | 1 |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 34.507.725 $ | +4.800.213 $ | +16,2 % | 1 | 29.707.512 $ | +15.119.254 $ | +103,6 % | 1 | 14.588.258 $ | +658.437 $ | +4,7 % | 1 |
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 31.901.763 $ | +8.622.577 $ | +37,0 % | 1 | 23.279.186 $ | +4.846.378 $ | +26,3 % | 1 | 18.432.808 $ | +18.432.808 $ | 1 | |
| Zenas BioPharma, Inc. | ZBIO | → 0 | Neutral | 30.990.403 $ | +4.722.031 $ | +18,0 % | 1 | ||||||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Neutral | 3.252.593 $ | -27.325.172 $ | -89,4 % | 1 | 30.577.765 $ | +9.373.775 $ | +44,2 % | 1 | ||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Neutral | 27.258.000 $ | +8.618.000 $ | +46,2 % | 1 | 18.640.000 $ | +5.460.000 $ | +41,4 % | 1 | 13.180.000 $ | +13.180.000 $ | 1 | |
| Minerva Neurosciences, Inc. | NERV | → 0 | Neutral | 23.991.246 $ | -2.053.305 $ | -7,9 % | 1 | 26.044.551 $ | +8.667.108 $ | +49,9 % | 1 | 17.377.443 $ | +17.377.443 $ | 1 | |
| Camp4 Therapeutics Corp | CAMP | → 0 | Neutral | 18.557.502 $ | -169.863 $ | -0,9 % | 1 | 18.727.365 $ | -7.304.097 $ | -28,1 % | 1 | 26.031.462 $ | +14.266.758 $ | +121,3 % | 1 |
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 25.964.000 $ | +6.236.000 $ | +31,6 % | 1 | 19.728.000 $ | +1.920.000 $ | +10,8 % | 1 | 17.808.000 $ | +5.176.000 $ | +41,0 % | 1 |
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Schwach | 20.022.352 $ | -3.401.767 $ | -14,5 % | 1 | 23.424.119 $ | +6.095.738 $ | +35,2 % | 1 | 17.328.381 $ | -20.190.867 $ | -53,8 % | 1 |
| Design Therapeutics, Inc. | DSGN | → 0 | Neutral | 23.338.706 $ | +6.177.418 $ | +36,0 % | 1 | 17.161.288 $ | +2.032.258 $ | +13,4 % | 1 | 15.129.030 $ | +15.129.030 $ | 1 | |
| Faeth Therapeutics, Inc. | FTH | → 0 | Schwach | 18.050.500 $ | -4.707.570 $ | -20,7 % | 1 | 22.758.070 $ | +22.758.070 $ | 1 | |||||
| Veradermics, Inc | MANE | → 0 | Neutral | 18.945.000 $ | +18.945.000 $ | 1 | |||||||||
| ACHIEVE LIFE SCIENCES, INC. | ACHV | → 0 | Neutral | 17.964.239 $ | +17.964.239 $ | 1 | |||||||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 8.404.756 $ | -1.612.423 $ | -16,1 % | 1 | 10.017.179 $ | -6.778.896 $ | -40,4 % | 1 | 16.796.075 $ | +2.053.686 $ | +13,9 % | 1 |
| AN2 Therapeutics, Inc. | ANTX | → 0 | Neutral | 15.263.618 $ | +4.478.169 $ | +41,5 % | 1 | 10.785.449 $ | +10.785.449 $ | 1 | |||||
| PepGen Inc. | PEPG | → 0 | Neutral | 4.185.000 $ | +69.750 $ | +1,7 % | 1 | 4.115.250 $ | -11.020.500 $ | -72,8 % | 1 | 15.135.750 $ | +4.394.250 $ | +40,9 % | 1 |
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 12.288.460 $ | +3.086.538 $ | +33,5 % | 1 | ||||||||
| Unicycive Therapeutics, Inc. | UNCY | → 0 | Sehr schwach | 2.579.500 $ | -9.198.147 $ | -78,1 % | 1 | 11.777.647 $ | +1.449.832 $ | +14,0 % | 1 | 10.327.815 $ | +2.523.781 $ | +32,3 % | 1 |
| Editas Medicine, Inc. | EDIT | → 0 | Neutral | 11.519.010 $ | +11.519.010 $ | 1 | |||||||||
| Odyssey Therapeutics, Inc. | ODTX | → 0 | Neutral | 10.758.250 $ | +10.758.250 $ | 1 | |||||||||
| EUPRAXIA PHARMACEUTICALS INC. | EPRX | → 0 | Neutral | 8.923.500 $ | -850.500 $ | -8,7 % | 1 | 9.774.000 $ | -418.500 $ | -4,1 % | 1 | 10.192.500 $ | +2.227.500 $ | +28,0 % | 1 |
| ABEONA THERAPEUTICS INC. | ABEO | → 0 | Neutral | 9.711.298 $ | -18.427 $ | -0,2 % | 1 | ||||||||
| OnKure Therapeutics, Inc. | OKUR | → 0 | Neutral | 8.790.358 $ | +809.639 $ | +10,1 % | 1 | 7.980.719 $ | +7.980.719 $ | 1 | |||||
| Verastem, Inc. | VSTM | → 0 | Neutral | 8.542.365 $ | -14.812.853 $ | -63,4 % | 1 | ||||||||
| Monopar Therapeutics | MNPR | → 0 | Schwach | 8.379.395 $ | +3.420.900 $ | +69,0 % | 1 | 4.958.495 $ | -951.155 $ | -16,1 % | 1 | 5.909.650 $ | -1.481.485 $ | -20,0 % | 1 |
| Aura Biosciences, Inc. | AURA | → 0 | Neutral | 8.283.336 $ | +8.283.336 $ | 1 | |||||||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 6.747.000 $ | -826.800 $ | -10,9 % | 1 | 7.573.800 $ | +1.697.800 $ | +28,9 % | 1 | 5.876.000 $ | +2.525.900 $ | +75,4 % | 1 |
| Silence Therapeutics plc | SLN | → 0 | Neutral | 6.721.160 $ | +983.854 $ | +17,1 % | 1 | ||||||||
| ALX ONCOLOGY HOLDINGS INC | ALXO | → 0 | Neutral | 6.592.356 $ | +207.006 $ | +3,2 % | 1 | 6.385.350 $ | +6.385.350 $ | 1 | |||||
| Satellos Bioscience Inc. | MSLE | → 0 | Neutral | 6.326.253 $ | +1.745.313 $ | +38,1 % | 1 | 4.580.940 $ | +4.580.940 $ | 1 | |||||
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 5.389.908 $ | +5.389.908 $ | 1 | |||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Sehr schwach | 5.082.000 $ | +5.082.000 $ | 1 | |||||||||
| SERA PROGNOSTICS, INC. | SERA | → 0 | 3.003.801 $ | -346.592 $ | -10,3 % | 1 | 3.350.393 $ | -1.518.405 $ | -31,2 % | 1 | 4.868.798 $ | -181.548 $ | -3,6 % | 1 | |
| Valneva SE | VALN | → 0 | 3.991.531 $ | +3.991.531 $ | 1 | ||||||||||
| Instil Bio, Inc. | TIL | → 0 | Schwach | 2.251.194 $ | -161.008 $ | -6,7 % | 1 | 2.412.202 $ | -807.971 $ | -25,1 % | 1 | 3.220.173 $ | -2.008.217 $ | -38,4 % | 1 |
| Pasithea Therapeutics Corp. | KTTA | → 0 | 239.904 $ | -1.317.876 $ | -84,6 % | 1 | 1.557.780 $ | -1.151.220 $ | -42,5 % | 1 | 2.709.000 $ | +2.709.000 $ | 1 | ||
| InMed Pharmaceuticals Inc. | INM | → 0 | 1.237.484 $ | +1.237.484 $ | 1 | ||||||||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 1.106.000 $ | +1.106.000 $ | 1 | |||||||||
| ENGENE HOLDINGS INC | → 0 | 843.736 $ | +843.736 $ | 1 | |||||||||||
| Bolt Biotherapeutics, Inc. | BOLT | → 0 | 278.794 $ | -13.759 $ | -4,7 % | 1 | 292.553 $ | -103.407 $ | -26,1 % | 1 | 395.960 $ | -540.700 $ | -57,7 % | 1 | |
| PRECISION BIOSCIENCES INC | DTIL | → 0 | Neutral | 36.746 $ | +11.033 $ | +42,9 % | 1 | 25.713 $ | +6.264 $ | +32,2 % | 1 | 19.449 $ | -6.357 $ | -24,6 % | 1 |
| Gesamt | 1.095.100.823 $ | +11.928.549 $ | +31,7 % | 47 | 1.202.954.264 $ | -464.012 $ | +10,6 % | 46 | 1.547.066.991 $ | +544.822.520 $ | +63,6 % | 47 | |||